Leveraging AlphaFold 3 for Structural Modeling of Neurological Disorder-Associated Proteins: A Pathway to Precision Medicine

Nishant Gadde,Sachi Dodamani,Rayaan Altaf,Sanjit Kumar
DOI: https://doi.org/10.1101/2024.11.18.624211
2024-11-20
Abstract:Accurate structural modeling of neurological disorder-causing proteins provides an important layer in unraveling the mechanism of disease and identifying therapeutic targets. This study utilizes AlphaFold 3, a state-of-the-art protein structure prediction platform, to model and interpret cis- and trans-pQTL-derived proteins associated with Alzheimer's disease, Parkinson's disease, and stroke. Using the NG00102 dataset, we created a high-resolution structure for more than 1,200 proteins expressed in Brain, CSF, and Plasma, providing tissue-specific protein structure analysis with associated functional implications. AlphaFold 3 predictions have illuminated key structure parameters including sequence length, average pLDDT confidence scores, and overall distribution of residues with confidence of >75% pLDDT. We used these features to determine the set of druggable proteins having optimal sequence lengths of 100-3000 residues, high structural reliability as evidenced by an average pLDDT > 80, and contain large regions of high-confidence residues. Tissue-specific mapping revealed unique mechanisms characterized by both cis and trans-pQTL effects, that have critical functional implications for how these genetic variants act in neurological disease pathways. Protein clusters by structural properties then led to more defined subgroups with potential implications for drug intervention. This integrated effort captures the strength of AlphaFold 3 in linking genetic variation to protein structure and function, providing a scalable pipeline for prioritizing therapeutic targets. Coupling our results with advanced predictive modeling and tissue-specific data sets provides a robust framework for uncovering new mechanisms and druggable targets in the research of Alzheimer's, Parkinson's, and stroke. This advances the field toward precision medicine.
Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: by using AlphaFold3 to perform high - precision structural modeling of proteins related to neurological diseases, thereby revealing the structural and functional characteristics of these proteins and identifying potential therapeutic targets. Specifically, this research aims to: 1. **Analyze the structures of proteins related to neurological diseases**: Accurate protein structure models are crucial for understanding the mechanisms of neurological diseases. This research uses AlphaFold3 to model proteins related to Alzheimer's disease, Parkinson's disease, and stroke to provide high - resolution structural information. 2. **Combine genetic variation and protein structure**: The research combines cis - and trans - pQTL (protein quantitative trait locus) data to explore how these genetic variations affect the function and expression patterns of proteins. This helps to understand the mechanism of action of genetic variation in neurological diseases. 3. **Identify potential therapeutic targets**: Through the analysis of protein structures, identify protein regions with high confidence and stability, especially those suitable for drug development. The research focuses on proteins with a sequence length between 100 - 3000 residues, an average pLDDT score > 80, and a large number of high - confidence residues (> 75% pLDDT). 4. **Construct a precision medicine framework**: By integrating multi - tissue proteomics data and genetic data, the research provides new ideas for precision medicine for neurological diseases. In particular, through the structural prediction of AlphaFold3, genetic variation can be better linked to protein function, providing guidance for drug discovery and treatment strategies. ### Specific problem summary: - **Objective**: Use AlphaFold3 to perform high - precision structural modeling of proteins related to neurological diseases. - **Method**: Combine cis - and trans - pQTL data to analyze the structural characteristics of proteins and their relationship with genetic variation. - **Application**: Identify potential therapeutic targets and promote the development of precision medicine for neurological diseases. ### Core formula: - **pLDDT (predicted Local Distance Difference Test)**: Used to evaluate the prediction confidence of each residue, and the formula is as follows: \[ \text{pLDDT}=\frac{1}{N}\sum_{i = 1}^{N}\left(1-\frac{\text{D}_{\text{pred}}(i)-\text{D}_{\text{true}}(i)}{\text{D}_{\text{max}}}\right) \] where \(N\) is the number of residues, \(\text{D}_{\text{pred}}(i)\) and \(\text{D}_{\text{true}}(i)\) are elements in the predicted and true distance matrices respectively, and \(\text{D}_{\text{max}}\) is the maximum possible distance difference. Through these efforts, this research provides an important basis for the mechanism research and drug development of neurological diseases, especially in the field of precision medicine.